Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Protein Complex Assembly02:41

Protein Complex Assembly

10.5K
Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
10.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

10.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
10.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Antimicrobial α-Peptoids/Polypeptoids: Molecular Design and Therapeutic Assemblies.

ACS infectious diseases·2026
Same author

Synthetic Polymers for Drug, Gene, and Vaccine Delivery.

Polymer science & technology (Washington, D.C.)·2026
Same author

Activatable Polymeric STING Agonist-Gold Nanorod Conjugate Driving STING Signaling and Immunogenic Activation in Colorectal Cancer Immunotherapy.

Nano letters·2026
Same author

Endoscopically Deliverable Polymer Adhesives with pH-Triggered Multiple Molecular Evolution for Gastric Ulcer Repair.

Journal of the American Chemical Society·2026
Same author

Epoxide apparent exchange reaction for the precise synthesis of epoxy resins.

Nature communications·2026
Same author

Biomimetic supported catalyst inspired by stalked crinoid.

Nature communications·2026

関連する実験動画

Updated: May 23, 2025

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.3K

バイオアクティブ・アセンブリ・コファクター・アシストド・ウルソリック・アシド・ヘリックス 強化された抗がん効果経由イン・シチュー ウイルスのような移行

Min Lin1, Dandan Liu1, Yiyu Gong1

  • 1State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, 130012 Changchun, China.

Journal of the American Chemical Society
|May 12, 2025
PubMed
まとめ

この研究は,がん治療のためのウルスロ酸 (UA) 投与を改善するためにポリペプトイドコファクターを使用する新しいナノプラットフォームを導入しています. プラットフォームは UA を強化します.

さらに関連する動画

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

16.7K
Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

13.8K

関連する実験動画

Last Updated: May 23, 2025

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.3K
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

16.7K
Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

13.8K

科学分野:

  • ナノ医療
  • バイオマテリアル科学
  • ガン治療薬

背景:

  • ウルソル酸 (UA) のようなペンタサイクリックトリテルペノイドは抗がん性があるが,溶解性や生物利用性が悪い.
  • 自然抗癌化合物の臨床翻訳は,製剤と配送の課題によって妨げられています.

研究 の 目的:

  • ウルソル酸 (UA) の供給と有効性を向上させるための新しいナノプラットフォームを開発する.
  • 腫瘍微環境 (TME) 内での刺激反応性ナノ構造形成のためのポリペプトイド組立コファクターを使用する.

主な方法:

  • 生物活性ポリペプトイドポリエレクトロライトとUAを刺激反応ナノ構造に組み込む.
  • TME誘発による放出のための酸反応性および標的特有の (乳酸) ナノ粒子の設計.
  • 細胞内ナノ粒子の変換,ミトコンドリアのターゲティング,UA放出メカニズムの調査.

主要な成果:

  • ナノプラットフォームは,酸性TMEの螺旋状繊維からウイルスのようなクラスターへのpH反応変換を実証し,腫瘍の浸透を向上させました.
  • チオエーテル結合の酸化によって誘発された細胞内 UA の放出はミトコンドリアの損傷とアポトーシスを引き起こした.
  • 個々の成分と比較して,腫瘍の成長抑制と転移の減少により,有意な相乗効果が観察されました.

結論:

  • 開発されたポリペプトイドアシストナノプラットフォームは,UAの溶解性,生物利用可能性,およびがん治療のための標的の投与を効果的に強化します.
  • このシナジスティックなアプローチは 先進的なナノ医療で自然化合物を活用して がん治療の成果を向上させる 有望な戦略です